FAKTOR-OPTIONSSCHEIN - SMITH & NEPHEW | Real-time Bid/Ask 01:45:36 27/06/2024 pm IST | ||
| 9.99 EUR / 10.04 EUR | +4.54% |
|
| Current month | -0.21% | ||
| 1 month | -6.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 9.58 | -3.62% |
| 25/24/25 | 9.94 | +7.00% |
| 24/24/24 | 9.29 | +4.26% |
| 21/24/21 | 8.91 | -4.30% |
| 20/24/20 | 9.31 | -4.61% |
Delayed Quote Börse Stuttgart
Last update June 26, 2024 at 05:19 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG2XMA |
| ISIN | DE000MG2XMA0 |
| Date issued | 24/04/2024 |
| Strike | 1,224 p |
| Maturity | Unlimited |
| Parity | 0.29 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.12 € |
|---|---|
| Lowest since issue | 7.92 € |
| Spread | 0.05 € |
| Spread % | 0.50% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.36
USD
Average target price
16.45
USD
Spread / Average Target
+33.14%
- Stock Market
- Certificates
- Certificat
